Leon G. Cooperman Increases Stake in DiaMedica Therapeutics Inc.

Leon G. Cooperman has filed an amendment to his Schedule 13G, disclosing an increased ownership in DiaMedica Therapeutics Inc. As of October 15, 2025, Cooperman beneficially owns 3,269,761 common shares, representing 6.3% of the total outstanding shares. This includes 2,450,000 shares held directly by Cooperman and 819,761 shares held by The Leon and Toby Cooperman Foundation. The filing indicates that the shares were not acquired for the purpose of influencing control of the issuer. The amendment reflects a significant increase in both the number of shares and the value of the holdings compared to previous filings.